EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactylation‐Driven NUPR1 Promotes Immunosuppression of Tumor‐Infiltrating Macrophages in Hepatocellular Carcinoma

Jialiang Cai, Peiling Zhang, Yufan Cai, Guiqi Zhu, Shiping Chen, Lina Song, Junxian Du, Biao Wang, Weixing Dai, Jian Zhou, Jia Fan, Yiyi Yu und 1 weitere

Advanced Science · 2025-05 · 12 (20)

DOI: 10.1002/advs.202413095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.04.2025. Verfasst von Jialiang Cai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor-Associated Macrophages, Basic Helix-Loop-Helix Proteins. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Leading Project of the Science and Technology Committee of Shanghai Municipality, Project of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While checkpoint immunotherapy effectively mobilizes T‐cell responses against tumors, its success in hepatocellular carcinoma (HCC) is frequently undermined by immunosuppressive myeloid cells within the tumor microenvironment. This study investigates the role of nuclear protein 1 (NUPR1), a gene prominently expressed in tumor‐associated macrophages (TAMs), in mediating this suppression and influencing immunotherapy outcomes. Through comprehensive analysis of single‐cell RNA sequencing (scRNA‐seq) datasets and functional assays in vitro and in vivo, NUPR1 is identified as a critical regulator within TAMs. The upregulation of NUPR1 is associated with enhanced M2 macrophage polarization and increased expression of immune checkpoints PD‐L1 and SIRPA, resulting in CD8+ T cell exhaustion and a diminished response to immunotherapy. Mechanistically, NUPR1 inhibits the ERK and JNK signaling pathways, thereby creating an immunosuppressive milieu conducive to tumor progression. Additionally, tumor‐derived lactate is shown to upregulate NUPR1 expression in macrophages via histone lactylation, perpetuating a feedback loop that intensifies immune suppression. Pharmacological targeting of NUPR1 reverses M2 polarization, curtails tumor growth, and augments the efficacy of PD‐1 blockade in preclinical models, positioning NUPR1 as both a potential biomarker for immunotherapy responsiveness and a therapeutic target to boost immunotherapy efficacy in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTumor-Associated MacrophagesBasic Helix-Loop-Helix ProteinsNeoplasm ProteinsHumansMiceAnimalsTumor MicroenvironmentImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

MAPK pathwayhistone lactylationimmune checkpoint blockadenuclear protein 1tumor‐associated macrophages (TMA)

Substanzen

Basic Helix-Loop-Helix ProteinsNeoplasm ProteinsNUPR1 protein, human

Autor:innen und Institutionen

  • Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, 200032, China.
  • Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, 200032, China.
  • Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Research Unit of Liver Cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing, 100000, China.

ORCID-Profile: Zhi Dai

Förderung

  • National Natural Science Foundation of China
  • Leading Project of the Science and Technology Committee of Shanghai Municipality
  • Project of Shanghai Municipal Health Commission
  • Chinese Society of Clinical Oncology research fund

Zitieren

APA

Cai, J., Zhang, P., Cai, Y., Zhu, G., Chen, S., Song, L., Du, J., Wang, B., Dai, W., Zhou, J., Fan, J., Yu, Y., & Dai, Z. (2025). Lactylation‐Driven NUPR1 Promotes Immunosuppression of Tumor‐Infiltrating Macrophages in Hepatocellular Carcinoma. Advanced Science, 12(20). https://doi.org/10.1002/advs.202413095

Vancouver

Cai J, Zhang P, Cai Y, Zhu G, Chen S, Song L, et al. Lactylation‐Driven NUPR1 Promotes Immunosuppression of Tumor‐Infiltrating Macrophages in Hepatocellular Carcinoma. Advanced Science. 2025;12(20). doi:10.1002/advs.202413095

BibTeX
@article{Cai2025,
  author = {Cai, Jialiang and Zhang, Peiling and Cai, Yufan and Zhu, Guiqi and Chen, Shiping and Song, Lina and Du, Junxian and Wang, Biao and Dai, Weixing and Zhou, Jian and Fan, Jia and Yu, Yiyi and Dai, Zhi},
  title = {Lactylation‐Driven NUPR1 Promotes Immunosuppression of Tumor‐Infiltrating Macrophages in Hepatocellular Carcinoma},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {20},
  doi = {10.1002/advs.202413095}
}
Kostenlos starten →